Printer Friendly

hTERT inhibition by Retinoic Acid derivatives in MCF-7 and T47D breast cancer cells.

Breast cancer, one of the leading causes of cancer-related death in women, has presented limited treatment options due to several factors including associated toxicity and a lack of sustained drug potency. Retinoid-induced inhibition of the telomerase enzyme has offered new hope in potential treatment of breast tumors with a decreased likelihood of adverse side effects. This enzyme, which maintains the telomeric ends of chromosomes, is silenced in almost all normal somatic tissue but is active in up to 95% of neoplastic tissue, including breast tumors. Retinoic acids have been shown in previous cancer studies to effectively enact a down-regulation of transcription of hTERT, the catalytic subunit of telomerase, associated with a marked decrease in telomerase activity as well as growth inhibition of transformed cells. In this study, MCF-7 and T47D human breast cancer cells were treated with therapeutic doses of 9-cis and UAB-30 retinoic acids (RA). UAB-30 RA, specifically, is a synthetic compound proven to be effective in animal studies of the treatment of breast cancer, but to this point has yet to be tested in human models. Following treatment, RT-PCR, TRAP assay, and AlamarBlue were utilized to assess hTERT mRNA levels, telomerase activity, and cell proliferation, respectively.

Rebecca C. Wylie, Nathaniel J. Hansen, Jonathan D. Matlock, James H. Jerkins, Mitchell S. Pate, Lucy G. Andrews and Trygve O. Tollefsbol. Dept. of Biology, Univ. of Ala. at Birmingham, AL 35294.
COPYRIGHT 2003 Alabama Academy of Science
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Biological Sciences
Author:Wylie, Rebecca C.; Hansen, Nathaniel J.; Matlock, Jonathan D.; Jerkins, James H.; Pate, Mitchell S.;
Publication:Journal of the Alabama Academy of Science
Article Type:Brief Article
Date:Apr 1, 2003
Words:230
Previous Article:Retinoic Acid inhibition of Dnmt expression and activity in HL-60 cells.
Next Article:Rapid detection of Vibrio parahaemolyticus in Gulf of Mexico water using real-time PCR.
Topics:


Related Articles
Drug combination may fight breast cancer.
Toxic Effects of Polynuclear Aromatic Hydrocarbons on Human Breast Cancer Cells.
Role of proteolysis in cell cycle control of breast cancer. (South Carolina Academy of Sciences Abstracts).
Effects of polychlorinated biphenyl Aroclor 1242 on MCF-7 cells. (South Carolina Academy of Sciences Abstracts).
Breast cancer stem cells: potential therapeutic targets.
Resveratrol fights breast cancer.
Reversal of the estrogen receptor--negative phenotype in breast cancer and restoration of antiestrogen response.
FoxA1 as a lineage-specific oncogene in luminal type breast cancer.
TNK2 preserves EGF receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters